心血管疾病危险因素、2 型糖尿病和弗雷明汉心脏研究。
Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study.
机构信息
Framingham Heart Study, National Heart, Lung, and Blood Institute, Division of Endocrinology, Metabolism, and Diabetes, Framingham, MA 01702, USA.
出版信息
Trends Cardiovasc Med. 2010 Apr;20(3):90-5. doi: 10.1016/j.tcm.2010.08.001.
Abstract
Type 2 diabetes is a common disorder and an important risk factor for cardiovascular disease. The Framingham Heart Study is a population-based epidemiologic study that has contributed to our knowledge of cardiovascular disease and its risk factors. This review will focus on the contemporary contributions of the Framingham Heart Study to the field of diabetes epidemiology, including data on diabetes trends, genetics, and future advances in population-based studies.
摘要
2 型糖尿病是一种常见疾病，也是心血管疾病的重要危险因素。弗雷明汉心脏研究是一项基于人群的流行病学研究，为我们了解心血管疾病及其危险因素做出了贡献。本综述将重点介绍弗雷明汉心脏研究在糖尿病流行病学领域的当代贡献，包括关于糖尿病趋势、遗传学和基于人群的研究未来进展的数据。
相似文献
1
Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study.心血管疾病危险因素、2 型糖尿病和弗雷明汉心脏研究。
Trends Cardiovasc Med. 2010 Apr;20(3):90-5. doi: 10.1016/j.tcm.2010.08.001.
2
A healthy lifestyle mitigates the risk of heart disease related to type 2 diabetes: a prospective nested case-control study in a nationwide Swedish twin cohort.健康的生活方式可降低 2 型糖尿病相关心脏病的发病风险：一项在全国性瑞典双胞胎队列中进行的前瞻性巢式病例对照研究。
Diabetologia. 2021 Mar;64(3):530-539. doi: 10.1007/s00125-020-05324-z. Epub 2020 Nov 10.
3
Coffee consumption and risk of type 2 diabetes and heart disease.咖啡饮用与2型糖尿病和心脏病风险
Nutr Rev. 2007 Apr;65(4):173-9. doi: 10.1111/j.1753-4887.2007.tb00297.x.
4
Cardiovascular disease in diabetes type 2: current concepts.2 型糖尿病中的心血管疾病：当前概念。
J Intern Med. 2018 Sep;284(3):240-253. doi: 10.1111/joim.12804. Epub 2018 Jul 18.
5
A systematic review of the factors associated with interest in predictive genetic testing for obesity, type II diabetes and heart disease.对与肥胖、II型糖尿病和心脏病预测性基因检测兴趣相关因素的系统评价。
J Hum Nutr Diet. 2014 Oct;27(5):479-88. doi: 10.1111/jhn.12179. Epub 2013 Nov 14.
6
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.糖尿病在女性中相当于心脏病吗？雷洛昔芬用于心脏（RUTH）试验中绝经后女性的一项国际研究结果。
Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):164-70. doi: 10.1161/CIRCOUTCOMES.112.966986. Epub 2013 Mar 12.
7
Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease.有利的肥胖与2型糖尿病、高血压和心脏病低风险之间存在关联的遗传学证据。
Diabetes. 2016 Aug;65(8):2448-60. doi: 10.2337/db15-1671. Epub 2016 Apr 26.
8
Proteasome modulator 9 and carpal tunnel syndrome.蛋白酶体调节剂 9 与腕管综合征。
Diabetes Res Clin Pract. 2011 Nov;94(2):e47-9. doi: 10.1016/j.diabres.2011.07.040. Epub 2011 Sep 8.
9
Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes.TCF7L2基因rs7903146位点对2型糖尿病患者临床表现及并发症风险的影响
Diabetes Obes Metab. 2025 Apr;27(4):2002-2011. doi: 10.1111/dom.16193. Epub 2025 Jan 8.
10
The Framingham Heart Study--67 years of discovery in metabolic disease.弗雷明汉心脏研究——代谢性疾病 67 年的探索。
Nat Rev Endocrinol. 2016 Mar;12(3):177-83. doi: 10.1038/nrendo.2015.226. Epub 2016 Jan 18.
引用本文的文献
1
Risk of Cardiovascular Disease According to the Precedence Relationship Between Hypertension and Diabetes Mellitus.根据高血压与糖尿病之间的先后关系看心血管疾病风险
Healthcare (Basel). 2025 Apr 2;13(7):796. doi: 10.3390/healthcare13070796.
2
Hypertensive Diabetic Patients: Casual Pulse Pressure and Ambulatory Blood Pressure Monitoring (ABPM) as Superior Predictors of Future Cardiovascular Events.高血压糖尿病患者：偶测脉压与动态血压监测（ABPM）作为未来心血管事件的更优预测指标
Cureus. 2025 Jan 25;17(1):e77974. doi: 10.7759/cureus.77974. eCollection 2025 Jan.
3
Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients With Type 2 Diabetes Mellitus Complicated With Cardiovascular Disease: A Network Meta-Analysis.新型抗糖尿病药物对2型糖尿病合并心血管疾病患者的心血管治疗益处：一项网状Meta分析
J Diabetes. 2025 Jan;17(1):e70044. doi: 10.1111/1753-0407.70044.
4
Predicting responsiveness to GLP-1 pathway drugs using real-world data.利用真实世界数据预测对胰高血糖素样肽-1（GLP-1）通路药物的反应性。
BMC Endocr Disord. 2024 Dec 18;24(1):269. doi: 10.1186/s12902-024-01798-9.
5
Effect of low-frequency blood glucose self-monitoring on glycosylated hemoglobin levels among older adults with type 2 diabetes mellitus.低频血糖自我监测对老年2型糖尿病患者糖化血红蛋白水平的影响。
J Res Med Sci. 2024 Sep 30;29:58. doi: 10.4103/jrms.jrms_20_23. eCollection 2024.
6
Impact of SGLT-2 inhibitors on modifiable cardiovascular risk factors in Romanian patients with type 2 diabetes mellitus.钠-葡萄糖协同转运蛋白2抑制剂对罗马尼亚2型糖尿病患者可改变心血管危险因素的影响。
Diabetol Metab Syndr. 2024 Apr 16;16(1):85. doi: 10.1186/s13098-024-01326-8.
7
Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.糖尿病血管病变：分子机制与临床新见
Int J Mol Sci. 2024 Jan 9;25(2):804. doi: 10.3390/ijms25020804.
8
SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain.钠-葡萄糖协同转运蛋白2抑制剂与胰高血糖素样肽-1受体激动剂在治疗心脏、肾脏和大脑方面的比较
J Cardiovasc Dev Dis. 2023 Jul 30;10(8):322. doi: 10.3390/jcdd10080322.
9
The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease.代谢指数、心血管健康与糖尿病合并心血管疾病的管理相关性。
Front Endocrinol (Lausanne). 2023 Jan 27;13:1036146. doi: 10.3389/fendo.2022.1036146. eCollection 2022.
10
Pharmacological Treatment of Type-2-Diabetes and Cardiovascular Comorbidities: Differences between Undocumented Migrants and Natives in Italy.2型糖尿病及其心血管合并症的药物治疗：意大利无证移民与本地人的差异
Healthcare (Basel). 2022 Dec 20;11(1):4. doi: 10.3390/healthcare11010004.
本文引用的文献
1
Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.起始年龄和筛查频率对 2 型糖尿病检测的影响：成本效益分析。
Lancet. 2010 Apr 17;375(9723):1365-74. doi: 10.1016/S0140-6736(09)62162-0. Epub 2010 Mar 29.
2
Effects of combination lipid therapy in type 2 diabetes mellitus.2 型糖尿病的联合降脂治疗效果。
N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14.
3
Effects of intensive blood-pressure control in type 2 diabetes mellitus.强化血压控制对 2 型糖尿病的影响。
N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.
4
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.新的遗传位点与空腹血糖稳态有关，及其对 2 型糖尿病风险的影响。
Nat Genet. 2010 Feb;42(2):105-16. doi: 10.1038/ng.520. Epub 2010 Jan 17.
5
Global estimates of the prevalence of diabetes for 2010 and 2030.全球 2010 年和 2030 年糖尿病患病率估计。
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. doi: 10.1016/j.diabres.2009.10.007. Epub 2009 Nov 6.
6
Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.弗明汉心脏研究中糖尿病患者与非糖尿病患者心血管疾病风险因素的趋势
Circulation. 2009 Jul 21;120(3):212-20. doi: 10.1161/CIRCULATIONAHA.108.846519. Epub 2009 Jul 6.
7
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.1950年至2005年弗雷明汉心脏研究中患糖尿病和未患糖尿病的男性与女性的全因死亡率和心血管疾病死亡率趋势
Circulation. 2009 Apr 7;119(13):1728-35. doi: 10.1161/CIRCULATIONAHA.108.829176. Epub 2009 Mar 23.
8
Glucose control and vascular complications in veterans with type 2 diabetes.2型糖尿病退伍军人的血糖控制与血管并发症
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.
9
Variants in MTNR1B influence fasting glucose levels.MTNR1B基因的变异会影响空腹血糖水平。
Nat Genet. 2009 Jan;41(1):77-81. doi: 10.1038/ng.290. Epub 2008 Dec 7.
10
Genotype score in addition to common risk factors for prediction of type 2 diabetes.除常见风险因素外，基因型评分对2型糖尿病的预测作用
N Engl J Med. 2008 Nov 20;359(21):2208-19. doi: 10.1056/NEJMoa0804742.
Zotero 插件